Remdesivir Shows Modest Improvement in Moderate COVID-19 Patients
2 Jun, 2020 | 04:59h | UTC- Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients – Reuters
- Expert reaction to press release announcing results of stage 3 trial of Gilead’s antiviral remdesivir in moderate patients – Science Media Centre
- Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show – STAT